Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

TCT 574: Efficacy of Ultrasound Renal Denervation Based Upon Changes in Detected Antihypertensive Medications Within the RADIANCE-HTN TRIO study

Presenter: Joost Daemen

October 27, 2025

Presentation TCT 2025

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

Presenter: David E. Kandzari

October 26, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

Clinicians Take Heed—High BP Merits Quick Action, Data Suggest

Caitlin E. Cox

July 17, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

CMS Issues Proposed Coverage Decision for Renal Denervation

Todd Neale

July 11, 2025

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

L.A. McKeown

July 10, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

Another Win for PREVENT, This Time in Older Adults

Yael L. Maxwell

May 06, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Conference News ISC 2025

Propranolol Linked to Stroke Protection in Women With Migraine

L.A. McKeown

February 06, 2025

News Daily News

High BP While Lying Down Signals Future CVD Risk

Todd Neale

January 22, 2025

Advertisement

TCT 574: Efficacy of Ultrasound Renal Denervation Based Upon Changes in Detected Antihypertensive Medications Within the RADIANCE-HTN TRIO study

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Clinicians Take Heed—High BP Merits Quick Action, Data Suggest

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

CMS Issues Proposed Coverage Decision for Renal Denervation

No Clear Risk of Dementia After TIA: Framingham Heart Study

FDA Approves Triple Therapy Polypill for High Blood Pressure

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

May 2025 Dispatch for the CV Team

Another Win for PREVENT, This Time in Older Adults

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Propranolol Linked to Stroke Protection in Women With Migraine

High BP While Lying Down Signals Future CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content